
Founder reality: MedTech doesn’t usually slow down because the idea is weak.
It slows down because evidence is scattered, partner handoffs get messy, and the next investor question lands like a brick through a window.
If you’re building in Houston, join us Thursday at TMC Innovation Factory for Pints & Prototypes, sponsored by Enlil.
Dr. Rafael Veraza, CEO of Vascular Perfusion Solutions, will share a practical look at how startups can better align evidence, capital, and partners before those cracks turn into expensive delays.
Great conversations, meaningful connections, and insights you can actually use on Friday morning. A rare combo.
Confirm your attendance here:
#Houston #MedTech #Founders #MedicalDeviceStartup #Investors #ContractManufacturing #TMC
It slows down because evidence is scattered, partner handoffs get messy, and the next investor question lands like a brick through a window.
If you’re building in Houston, join us Thursday at TMC Innovation Factory for Pints & Prototypes, sponsored by Enlil.
Dr. Rafael Veraza, CEO of Vascular Perfusion Solutions, will share a practical look at how startups can better align evidence, capital, and partners before those cracks turn into expensive delays.
Great conversations, meaningful connections, and insights you can actually use on Friday morning. A rare combo.
Confirm your attendance here:
#Houston #MedTech #Founders #MedicalDeviceStartup #Investors #ContractManufacturing #TMC
Shared byRiley Silva - 14 days ago
Log in to comment
Loading ..
Related Articles
Record Q1 2026: Eight MedTech Innovators Choose Enlil
Record Quarter for Enlil: Welcoming 8 New MedTech Innovators in Q1 2026
Join the Houston MedTech Community for a Practical Insight on Startup Challenges
Enlil Joins NEMIC as Corporate Member, Advances MedTech Innovation
Unlocking Success for MedTech Startups: Evidence, Capital, and Partnerships
Enlil Partners with Celerity MedTech to Enhance MedTech Development Processes
6
0/100